Fri, August 6, 2021

Keay Nakae Maintained (ARWR) at Strong Buy with Decreased Target to $94 on, Aug 6th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-94-on-aug-6th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Keay Nakae of Chardan Capital, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy with Decreased Target from $97 to $94 on, Aug 6th, 2021.

Keay, nor any peers, have made any analyst calls on ARWR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30